Currently Enrolling Studies
To learn more, call 319-356-4848 or e-mail recruit-vaccine-research@uiowa.edu.
A phase 1, comparator-controlled, dosage-escalation study to evaluate the safety and immunogenicity of two doses DCVC H1 HA mRNA-LNP in healthy adults.
Complete this survey to see if you are eligible!
Ongoing Studies (Closed to Enrollment)
A phase 3 study to evaluate the safety, tolerability, and immunogenicity of a respiratory syncytial virus (RSV) prefusion F subunit vaccine in adults at high risk of severe RSV disease.
A phase 1/2 randomized, observer-blind study to evaluate the safety, tolerability, and immunogenicity of a modified RNA vaccine against varicella zoster virus in healthy individuals.
A Phase 1b, double-blind, randomized, dose-escalating, age de-escalating, placebo-controlled study to assess the safety and immunogenicity of one or two doses of Sing2016 M2SR H3N2 influenza vaccine delivered intranasally in a healthy pediatric population 6 months through 17 years of age.